F1-V 融合蛋白

NR-2563??Yersinia pestis, F1-V Fusion Protein, Dimer-Enriched Antigen, Recombinant from Escherichia coli(Proteins)|Yersinia pestis|F1-V Fusion Protein, Dimer-Enriched Antigen, Recombinant from Escherichia coli|-70°C or colder|NIAID/NIHAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Yersinia pestis F1-V Fusion Protein, Dimer-Enriched Antigen, Recombinant from Escherichia coli, NR-2563."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.Recombinant Yersinia pestis (Y. pestis) F1-V fusion protein, dimer-enriched antigen was purified from Escherichia coli and depleted of DNA and endotoxin. Originally developed by the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID), F1-V is a fusion protein consisting of the Fraction 1 (F1) capsular protein and the virulence-associated (V) regulatory protein from Y. pestis (GenPept: AAY23169). NR-2563 was demonstrated to be functionally active based on its reactivity with antibodies to both the F1 and V proteins. NR-2563 is protective in a Y. pestis lethal challenge murine model.Each vial contains approximately 1.5 mg of recombinant F1-V fusion protein in 20 mM L-arginine, 10 mM sodium chloride, 1 mM L-cysteine.

NR-2562??Yersinia pestis, F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli(Proteins)|Yersinia pestis|F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli|-70°C or colder|NIAID/NIHAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Yersinia pestis F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli, NR-2562."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.This product is also available as BEI Resources NR-2561. Please note that each vial of NR-2561 contains approximately 1.5 mg of F1-V fusion protein, while each vial of NR-2562 contains approximately 0.6 mg of F1-V fusion protein.Recombinant Yersinia pestis (Y. pestis) F1-V fusion protein, monomer-enriched antigen was purified from Escherichia coli and depleted of DNA and endotoxin. Originally developed by the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID), F1-V is a fusion protein consisting of the Fraction 1 (F1) capsular protein and the virulence-associated (V) regulatory protein from Y. pestis (GenPept: AAY23169). NR-2562 was demonstrated to be functionally active based on its reactivity with antibodies to both the F1 and V proteins. NR-2562 is protective in a Y. pestis lethal challenge murine model.Each vial of NR-2562 contains lyophilized (approximately 0.6 mg in 20 mM L-arginine, 10 mM sodium chloride, 1 mM L-cysteine, and 2% w/v D-mannitol) recombinant F1-V fusion protein. NR-2562 should be reconstituted with 0.5 mL of sterile water.

NR-2561??Yersinia pestis, F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli(Proteins)|Yersinia pestis| F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli|-70°C or colder|NIAID/NIHAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Yersinia pestis F1-V Fusion Protein, Monomer-Enriched Antigen, Recombinant from Escherichia coli, NR-2561."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.This product is also available as BEI Resources NR-2562. Please note that each vial of NR-2561 contains approximately 1.5 mg of F1-V fusion protein, while each vial of NR-2562 contains approximately 0.6 mg of F1-V fusion protein.Recombinant Yersinia pestis (Y. pestis) F1-V fusion protein, monomer-enriched antigen was purified from Escherichia coli and depleted of DNA and endotoxin. Originally developed by the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID), F1-V is a fusion protein consisting of the Fraction 1 (F1) capsular protein and the virulence-associated (V) regulatory protein from Y. pestis (GenPept: AAY23169). NR-2561 was demonstrated to be functionally active based on its reactivity with antibodies to both the F1 and V proteins. NR-2561 is protective in a Y. pestis lethal challenge murine model.Each vial contains approximately 1.5 mg of recombinant F1 V fusion protein in 20 mM L-arginine, 10 mM sodium chloride and 1 mM L-cysteine.